Bicyclic heterocycle compounds and their uses in therapy
US-2025296930-A1 · Sep 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Saxty Gordon patents
Saxty Gordon is listed as an inventor on 38 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Saxty Gordon |
| Total patents | 38 |
| First publication | Jan 29, 2015 |
| Latest publication | Sep 25, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Bicyclic heterocycle compounds and their uses in therapy
US-12202828-B2 · Jan 21, 2025 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2023227450-A1 · Jul 20, 2023 · US
Bicyclic heterocycle compounds and their uses in therapy
US-11643410-B2 · May 9, 2023 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2022204503-A1 · Jun 30, 2022 · US
Pyrrolopyrimidine and pyrrolopyridine derivatives
US-2022169653-A1 · Jun 2, 2022 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2022135544-A1 · May 5, 2022 · US
Bicyclic heterocycle compounds and their uses in therapy
US-11225476-B2 · Jan 18, 2022 · US
Pyrrolopyrimidine and pyrrolopyridine derivatives
US-11136325-B2 · Oct 5, 2021 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2020325134-A1 · Oct 15, 2020 · US
Recent patents
Latest publications not already listed above.
Pyrrolopyrimidine and pyrrolopyridine derivatives
US-2020165259-A1 · May 28, 2020 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2020131153-A1 · Apr 30, 2020 · US
Bicyclic heterocycle compounds and their uses in therapy
US-10618895-B2 · Apr 14, 2020 · US
Pyrazolyl quinoxaline kinase inhibitors
US-10519137-B2 · Dec 31, 2019 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-10052320-B2 · Aug 21, 2018 · US
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
US-10045982-B2 · Aug 14, 2018 · US
Quinolines as FGFR kinase modulators
US-10039759-B2 · Aug 7, 2018 · US
Bicyclic heterocycle compounds and their uses in therapy
US-9980973-B2 · May 29, 2018 · US
Pyrazolyl quinoxaline kinase inhibitors
US-2018127397-A1 · May 10, 2018 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2018065959-A1 · Mar 8, 2018 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9856236-B2 · Jan 2, 2018 · US
Bicyclic heterocycle compounds and their uses in therapy
US-9783538-B2 · Oct 10, 2017 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2017224705-A1 · Aug 10, 2017 · US
Bicyclic heterocycle compounds and their uses in therapy
US-9663512-B2 · May 30, 2017 · US
Bicyclic heterocycle compounds and their uses in therapy
US-9617248-B2 · Apr 11, 2017 · US
Bicyclic heterocycle compounds and their uses in therapy
US-9617283-B2 · Apr 11, 2017 · US
Bicyclic heterocycle compounds and their uses in therapy
US-2017029419-A1 · Feb 2, 2017 · US
Quinolines as fgfr kinase modulators
US-2017000781-A1 · Jan 5, 2017 · US
Quinolines as FGFR kinase modulators
US-9439896-B2 · Sep 13, 2016 · US
SUBSTITUTED PYRIDO[2,3-b]PYRAZINES AS FGFR KINASE INHIBITORS
US-2016235744-A1 · Aug 18, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Astex Therapeutics Ltd | 41 |
| Galapagos Nv | 3 |
| Calchan Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 33 |
| C07D471/04 | 27 |
| A61K31/5377 | 27 |
| A61P43/00 | 27 |
| C07D413/14 | 24 |